Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul 9;17(1):117.
doi: 10.1186/s12957-019-1660-2.

Intrapancreatic accessory spleen false positive to 68Ga-Dotatoc: case report and literature review

Affiliations
Review

Intrapancreatic accessory spleen false positive to 68Ga-Dotatoc: case report and literature review

Francesco Lancellotti et al. World J Surg Oncol. .

Abstract

Background: Intrapancreatic accessory spleen (IPAS) is an uncommon finding of pancreatic mass. Differential diagnosis with pancreatic tumor, especially with non-functional neuroendocrine tumor (NF-NET), may be very hard and sometimes it entails unnecessary surgery. A combination of CT scan, MRI, and nuclear medicine can confirm the diagnosis of IPAS. 68-Ga-Dotatoc PET/CT is the gold standard in NET diagnosis and it can allow to distinguish between IPAS and NET.

Case presentation: A 69-year-old man was admitted to our hospital for an incidental nodule in the tail of the pancreas with focal uptake of 68-Ga-dotatate at PET/CT. NET was suspected and open distal splenopancreatectomy was performed. Pathologic examination revealed an IPAS.

Conclusion: This is the second IPAS case in which a positive 68Ga-Dotatoc uptake led to a false diagnosis of pancreatic NET. Here is a proposal of a literature review.

Keywords: False positive to 68Ga-Dotatoc; Intrapancreatic accessory spleen; Neuroendocrine tumor; Pancreatic mass.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Incidental mass in the tail of the pancreas (arrow). CT revealed a mass well delimited with homogeneous contrast enhancement. a Venous and b arterial phase axial CT images
Fig. 2
Fig. 2
MRI confirmed a 2-cm nodule of the tail of the pancreas hypointense on T1 (a) and hyperintense on T2 (b)-weighted sequence with a focal lesion inside hyperintense on T1. Diffusion-weighted MR imaging shows a high restriction (c) and hypointense in T1 fat sat sequence (d)
Fig. 3
Fig. 3
The PET image shows an indeterminate pancreatic tail nodule with enhanced uptake of 68-Ga-dotatate at PET-CT fusion image (false positive)
Fig. 4
Fig. 4
Gross pathologic findings of IPAS: S the main spleen; P the tail of the pancreas. The arrow shows a reddish nodule with epidermoid cyst surrounded by pancreatic parenchyma
Fig. 5
Fig. 5
Microscopic findings (hematoxylin and eosin staining). a, b It is possible to observe the interface between pancreatic parenchyma (red arrow) and accessory spleen with epidermoid cyst (yellow arrow) (H&E, × 4). c Histological picture of intrapancreatic splenic parenchyma with adjacent normal pancreas (H&E, × 40). d Multiseptated intrasplenic epithelial cyst, with multilayered squamous epithelium (H&E, × 40)

References

    1. Bostanci EB, Oter V, Okten S, Küçük NO, Soydal C, Turhan N, et al. Intra-pancreatic accessory spleen mimicking pancreatic neuroendocrine tumor on 68-ga-dotatate PET/CT. Arch Iran Med. 2016;19:816–819. - PubMed
    1. Kawamoto S, Johnson PT, Hall H, Cameron JL, Hruban RH, Fishman EK. Intrapancreatic accessory spleen: CT appearance and differential diagnosis. Abdom Imaging. 2012;37(5):812–827. doi: 10.1007/s00261-011-9830-x. - DOI - PubMed
    1. Halpert B, Gyorkey F. Lesions observed in accessory spleens of 311 patients. Am J Clin Pathol. 1959;32(2):165–168. doi: 10.1093/ajcp/32.2.165. - DOI - PubMed
    1. Bhutiani N, Egger ME, Doughtie CA, Burkardt ES, Scoggins CR, Martin RC, 2nd, et al. Intrapancreatic accessory spleen (IPAS): a single-institution experience and review of the literature. Am J Surg. 2017;213(4):816–820. doi: 10.1016/j.amjsurg.2016.11.030. - DOI - PubMed
    1. Gastrointestinal Pathology Study Group of Korean Society of Pathologists. Cho MY, Kim JM, Sohn JH, Kim MJ, Kim KM, Kim WH, et al. Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors ( GEP-NETs ) in Korea 2000-2009: Multicenter Study. Cancer Res Treat. 2012;44(3):157–165. doi: 10.4143/crt.2012.44.3.157. - DOI - PMC - PubMed

MeSH terms

Substances